4//SEC Filing
YAMANOUCHI VENTURE CAPITAL LLC 4
Accession 0001209191-04-020336
CIK 0001062216other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 5:09 PM ET
Size
14.4 KB
Accession
0001209191-04-020336
Insider Transaction Report
Form 4
Transactions
- Conversion
Series D Convertible Preferred Shares
2004-04-08−1,395,349→ 0 total(indirect: See Footnote)→ Common Stock (465,116 underlying) - Conversion
Common Stock
2004-04-08+465,116→ 465,116 total(indirect: See Footnote)
Transactions
- Conversion
Series D Convertible Preferred Shares
2004-04-08−1,395,349→ 0 total(indirect: See Footnote)→ Common Stock (465,116 underlying) - Conversion
Common Stock
2004-04-08+465,116→ 465,116 total(indirect: See Footnote)
Transactions
- Conversion
Common Stock
2004-04-08+465,116→ 465,116 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Shares
2004-04-08−1,395,349→ 0 total(indirect: See Footnote)→ Common Stock (465,116 underlying)
Footnotes (4)
- [F1]The shares of Series D Convertible Preferred Stock reported consist of shares held of record by each of the entities listed below. Yamanouchi Venture Capital, LLC is 100% owned by Yamanouchi Group Holding, Inc., which is in turn owned by Yamanouchi Pharmaceutical Co., Ltd. Each of the Filing Persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
- [F2]Each share of Convertible Preferred Stock converted into .3333 shares of Common Stock.
- [F3]These securities automatically converted into Common Stock upon the closing of the issuer?s initial public offering.
- [F4]These securities do not have an expiration date.
Issuer
MEMORY PHARMACEUTICALS CORP
CIK 0001062216
Entity typeother
Related Parties
1- filerCIK 0001284394
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 5:09 PM ET
- Size
- 14.4 KB